Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Asunto de la revista
Intervalo de año de publicación
1.
Arterioscler Thromb Vasc Biol ; 37(5): 823-835, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-28336561

RESUMEN

OBJECTIVE: Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is a collagen receptor that belongs to the inhibitory immunoreceptor tyrosine-based inhibition motif-containing receptor family. It is an inhibitor of signaling via the immunoreceptor tyrosine-based activation motif-containing collagen receptor complex, glycoprotein VI-FcRγ-chain. It is expressed on hematopoietic cells, including immature megakaryocytes, but is not detectable on platelets. Although the inhibitory function of LAIR-1 has been described in leukocytes, its physiological role in megakaryocytes and in particular in platelet formation has not been explored. In this study, we investigate the role of LAIR-1 in megakaryocyte development and platelet production by generating LAIR-1-deficient mice. APPROACH AND RESULTS: Mice lacking LAIR-1 exhibit a significant increase in platelet counts, a prolonged platelet half-life in vivo, and increased proplatelet formation in vitro. Interestingly, platelets from LAIR-1-deficient mice exhibit an enhanced reactivity to collagen and the glycoprotein VI-specific agonist collagen-related peptide despite not expressing LAIR-1, and mice showed enhanced thrombus formation in the carotid artery after ferric chloride injury. Targeted deletion of LAIR-1 in mice results in an increase in signaling downstream of the glycoprotein VI-FcRγ-chain and integrin αIIbß3 in megakaryocytes because of enhanced Src family kinase activity. CONCLUSIONS: Findings from this study demonstrate that ablation of LAIR-1 in megakaryocytes leads to increased Src family kinase activity and downstream signaling in response to collagen that is transmitted to platelets, rendering them hyper-reactive specifically to agonists that signal through Syk tyrosine kinases, but not to G-protein-coupled receptors.


Asunto(s)
Plaquetas/metabolismo , Megacariocitos/metabolismo , Activación Plaquetaria , Receptores Inmunológicos/deficiencia , Trombocitosis/sangre , Trombosis/sangre , Animales , Plaquetas/efectos de los fármacos , Proteínas Portadoras/farmacología , Células Cultivadas , Cloruros , Modelos Animales de Enfermedad , Activación Enzimática , Compuestos Férricos , Predisposición Genética a la Enfermedad , Megacariocitos/efectos de los fármacos , Ratones Noqueados , Péptidos/farmacología , Fenotipo , Activación Plaquetaria/efectos de los fármacos , Complejo GPIIb-IIIa de Glicoproteína Plaquetaria/metabolismo , Glicoproteínas de Membrana Plaquetaria/agonistas , Glicoproteínas de Membrana Plaquetaria/metabolismo , Receptores de IgG/sangre , Receptores Inmunológicos/genética , Transducción de Señal/efectos de los fármacos , Trombocitosis/genética , Trombosis/inducido químicamente , Trombosis/genética , Familia-src Quinasas/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA